Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine the long term safety of Enbrel in adults with active rheumatoid arthritis in Luxemburg. This is a post-marketing surveillance study in rheumatology practice patients. All patients initiated with Enbrel will be observed from the start of the study in Feb 2003 for a period of at least 5 years.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Collaborator: Innovex, Inc
• Treatments: Etanercept

Criteria

Inclusion Criteria:

• Have moderate to severe active rheumatoid arthritis

• Be aged of 17 years or more

• Have inadequate response to DMards

• Give written informed consent

• Physician decides to prescribe Enbrel

Exclusion Criteria:

n/a